CTRI/2008/091/000247尚未招募2 期
COMPARATIVE EVALUATION OF ACTEOSIDE AND SILYMARIN AS HEPATOPROTECTIVE AGENTS IN ACUTE HEPATITIS PATIENTS-A RANDOMIZED PROSPECTIVE OPEN FRAME STUDY
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Acute Hepatitis Patients of different etiologies in the age group of 20-65 years and would be required to abstain from any alternative medication or vitamin supplements during the study.
排除标准
- •1. Patients having any other concomitant disease
- •2.Patients receiving any other medication affecting hepatic function
- •3. Patients having received any hepatoprotective agent in the recent past or currently on any hepatoprotective agent 4.Patients with history of smoking, alcohol or any other substance abuse.
- •5. Pregnancy and lactation.
- •6. Has participated in any investigational study 4 weeks prior to the enrollment in this study.
- •7. Known history of hypersensitivity reactions.
研究者
相似试验
招募中
2 期
Comparison the effects of silymarin and N-acetylcysteine on improvement of, Hepatic and renal Abnormalities in Patients with SeverePreeclampsia in post-partumPreeclampcia.Severe pre-eclampsiaO14.1IRCT20191231045965N1Shahre-kord University of Medical Sciences60
尚未招募
4 期
COMPARING EFFECTIVENESS OF CAPSULE SILYMARIN WITH THAT OF SM FIBRO CAPSULE IN THE MANAGEMENT OF ORAL SUBMUCOUS FIBROSISCTRI/2024/01/061326KAKARLA VENKATA SUSMITHA
尚未招募
4 期
A study to compare safety and efficacy of silodosin versus mirabegron in patients with lower uretericstoneCTRI/2023/08/057036Dr Rajendera Prasad Government Medical College, Kangra at Tanda, Himachal Pradesh India
尚未招募
3 期
Evaluate efficacy and safety of combination of Silodosin and Tadalafil vs. Silodosin or Tadalafil alone in patients with enlarged prostateCTRI/2020/07/026440I
尚未招募
2 期
Silymarin capsule in COVID-19COVID-19 disease.COVID-19U07.1IRCT20180103038199N10Mashhad University of Medical Sciences140